Astellas' engagement in sustainability
Astellas recognizes our contribution to environmental and social sustainability is essential for our business continuity.
Astellas is committed to engaging in the sustainability of society by fulfilling our social responsibilities as a pharmaceutical company, including but not limited to providing our products such as a pharmaceutical products that satisfy unmet medical needs. As a result, we earn trust from society for both the Company and our products, which enhances Astellas’ sustainability.
This positive cycle will lead to the realization of our mission, "sustainable enhancement of enterprise value" through fulfillment of our raison d'etre "contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products." In short, for Astellas, contributing to the sustainability of society means the realization of its philosophy.
The activities we have carried out under the aforementioned philosophy continue to be well-received externally.
For example, Astellas has been named to the FTSE4Good Index Series, a representative investment index, for tenth consecutive years. Astellas is also included as a constituent in all of the ESG investment indexes adopted by the Government Pension Investment Fund (GPIF) in Japan, which are FTSE Blossom Japan Index, MSCI Japan ESG Select Leaders Index, MSCI Japan Empowering Women Index (WIN) and S&P/JPX Carbon Efficient Index.
Two Aspects of Sustainability through our activities
Sustainability that Astellas is engaged in has two aspects: value creation and value protection.
Through its business activities, Astellas is creating value for society by addressing social issues such as unmet medical needs, and by rewarding stakeholders.
By reinvesting the profit we gain through business activities, we strengthen our capabilities in research and development. In addition, by winning trust from government and business partners in each country, we create new business opportunities. That is to say, value for Astellas is created.
Astellas seeks to reduce its environmental burden, preserve biodiversity, ensure compliance, and takes measures to prevent corruption. In addition to the social value of these activities, they contribute to mitigating reputation risks and elevating Astellas' corporate brand, thereby protecting our enterprise value.
Governance of Astellas’ Sustainability
Astellas Pharma Inc. (Astellas) has established the Sustainability Advisory Panel, and Environment, Social or Governance Working Group composed of cross-functional members led by Corporate Advocacy. We promote long-term, strategic and global sustainability enhancement activities by all departments.
Sustainability Advisory Panel
The panel ‘s primary focus is on Astellas’ sustainability issues that are overarching to Environment, Social and Governance matters.
Environment, Social or Governance Working Group
With reference to various principles, guidelines and the external environment, each Working Group identifies important ESG matters for the company to manage and creates advocacy strategy.
Sustainability, Corporate Advocacy
Sustainability, Corporate Advocacy is responsible for working as a secretariat of Sustainability Advisory Panel and each Working Group and responding to sustainability matters throughout the entire Astellas Group, raising sustainability awareness internally and externally in collaboration with communication functions.